Skip to main content

How should we describe the radioblologic effect of extracranial stereotactic radlosurgery: equivalent uniform dose or tumor control probability?

Publication ,  Journal Article
Kavanagh, BD; Timmerman, RD; Benedict, SH; Wu, Q; Schefter, TE; Stuhr, K; McCourt, S; Newman, F; Cardinale, RM; Gaspar, LF
Published in: Med Phys
March 2003

Extracranial stereotactic radiosurgery (ESR) is now undergoing clinical investigation at numerous institutions as a treatment for solitary malignant lesions. Because there is no standard ESR technique, the same minimum dose might be applied through widely variable target dose-volume histograms. For multicenter trials of ESR or interinstitutional comparisons, a reliable index of radiobiological dose equivalency might facilitate the evaluation of dose-response relationships. Equivalent uniform dose (EUD) and tumor control probability (TCP) were considered for this application. While EUD appears more robust for the prospective description of ESR, TCP is expected to remain more valuable for a post hoc estimation of radiosensitivity parameters.

Duke Scholars

Published In

Med Phys

DOI

ISSN

0094-2405

Publication Date

March 2003

Volume

30

Issue

3

Start / End Page

321 / 324

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Sensitivity and Specificity
  • Radiotherapy Planning, Computer-Assisted
  • Radiotherapy Dosage
  • Radiosurgery
  • Radiometry
  • Radiation Tolerance
  • Nuclear Medicine & Medical Imaging
  • Humans
  • Cell Survival
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Kavanagh, B. D., Timmerman, R. D., Benedict, S. H., Wu, Q., Schefter, T. E., Stuhr, K., … Gaspar, L. F. (2003). How should we describe the radioblologic effect of extracranial stereotactic radlosurgery: equivalent uniform dose or tumor control probability? Med Phys, 30(3), 321–324. https://doi.org/10.1118/1.1543571
Kavanagh, B. D., R. D. Timmerman, S. H. Benedict, Q. Wu, T. E. Schefter, K. Stuhr, S. McCourt, F. Newman, R. M. Cardinale, and L. F. Gaspar. “How should we describe the radioblologic effect of extracranial stereotactic radlosurgery: equivalent uniform dose or tumor control probability?Med Phys 30, no. 3 (March 2003): 321–24. https://doi.org/10.1118/1.1543571.
Kavanagh BD, Timmerman RD, Benedict SH, Wu Q, Schefter TE, Stuhr K, et al. How should we describe the radioblologic effect of extracranial stereotactic radlosurgery: equivalent uniform dose or tumor control probability? Med Phys. 2003 Mar;30(3):321–4.
Kavanagh, B. D., et al. “How should we describe the radioblologic effect of extracranial stereotactic radlosurgery: equivalent uniform dose or tumor control probability?Med Phys, vol. 30, no. 3, Mar. 2003, pp. 321–24. Pubmed, doi:10.1118/1.1543571.
Kavanagh BD, Timmerman RD, Benedict SH, Wu Q, Schefter TE, Stuhr K, McCourt S, Newman F, Cardinale RM, Gaspar LF. How should we describe the radioblologic effect of extracranial stereotactic radlosurgery: equivalent uniform dose or tumor control probability? Med Phys. 2003 Mar;30(3):321–324.

Published In

Med Phys

DOI

ISSN

0094-2405

Publication Date

March 2003

Volume

30

Issue

3

Start / End Page

321 / 324

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Sensitivity and Specificity
  • Radiotherapy Planning, Computer-Assisted
  • Radiotherapy Dosage
  • Radiosurgery
  • Radiometry
  • Radiation Tolerance
  • Nuclear Medicine & Medical Imaging
  • Humans
  • Cell Survival